How it went for everyone who tried it
Helped means they said it helped with what they took it for, which may be one symptom and not the illness.
Shares are out of the 7 people who said how it went. 2 more tried it without saying how it went.
| How it went | People | Share |
|---|---|---|
| Helped a lot | 0 | 0% |
| Helped | 2 | 29% |
| No change | 2 | 28% |
| Worse | 3 | 43% |
| Much worse | 0 | 0% |
Shares are rounded to add up to 100, so two equal counts can show a point apart.
| Where it was reported | Helped | Said how it went |
|---|---|---|
| 2 | 5 | |
| Recovery stories | 0 | 2 |
How it went for everyone who tried it
Helped means they said it helped with what they took it for, which may be one symptom and not the illness.
Shares are out of the 2 people who said how it went.
| How it went | People | Share |
|---|---|---|
| Helped a lot | 0 | 0% |
| Helped | 0 | 0% |
| No change | 2 | 100% |
| Worse | 0 | 0% |
| Much worse | 0 | 0% |
How it went for everyone who tried it
Helped means they said it helped with what they took it for, which may be one symptom and not the illness.
Shares are out of the 5 people who said how it went. 2 more tried it without saying how it went.
| How it went | People | Share |
|---|---|---|
| Helped a lot | 0 | 0% |
| Helped | 2 | 40% |
| No change | 0 | 0% |
| Worse | 3 | 60% |
| Much worse | 0 | 0% |
| Where it was reported | Helped | Said how it went |
|---|---|---|
| 2 | 3 | |
| Recovery stories | 0 | 2 |
Ask about this treatment
The one person who credits it with their improvement: here’s how they are now
Credit it means they say it’s one reason they got better: 1 says it helped them most.
Where each person was at the end of their story, or in their latest post that says how they are, compared with their worst point.
| Outcome described | People | Share |
|---|---|---|
| Recovered | 0 | 0% |
| Near normal | 0 | 0% |
| Much better | 0 | 0% |
| Somewhat better | 0 | 0% |
| Relapsed | 1 | 100% |
Did it last?
- 1 of 1 who credits it said its benefit wore off; that person is the one who relapsed.
- No one says they still need to keep doing something to stay well.
No one with long COVID credits it with their improvement
Credit it means they say it’s one reason they got better.
The one person who credits it with their improvement: here’s how they are now
Credit it means they say it’s one reason they got better: 1 says it helped them most.
Where each person was at the end of their story, or in their latest post that says how they are, compared with their worst point.
| Outcome described | People | Share |
|---|---|---|
| Recovered | 0 | 0% |
| Near normal | 0 | 0% |
| Much better | 0 | 0% |
| Somewhat better | 0 | 0% |
| Relapsed | 1 | 100% |
Did it last?
- 1 of 1 who credits it said its benefit wore off; that person is the one who relapsed.
- No one says they still need to keep doing something to stay well.
Everyone · not split by condition
By how ill people were
Only the one person who credits it, so people it didn’t help or made worse aren’t here. How they are now is their outcome overall, not the effect of this one treatment.
| Severity at worst | How they are now | n | Recovered or near normal |
|---|---|---|---|
| Not stated | 1 | 0%, few people |
| At worst | Outcome | People | Share |
|---|---|---|---|
| Not stated | Relapsed | 1 of 1 | 100% |
Everyone · not split by condition
What people started next
5 of the 7 people who said how it went saw no change or got worse. 4 of those 5 say what they started next.
Everyone · not split by condition
Adverse events
What people said went wrong, in their own words.
4 of 9
people who wrote about taking it described a problem they tied to it
The serious kinds
Worth telling a doctor about straight away.
Liver or kidney problems
2 people“On a trial of Arava (which I halted) I got a boil in my armpit & my liver was affected by the drug.”
— merylg “I had labs done at the same time and got a call today that my liver isn’t tolerating the Arava.”
— Pond 20039
The serious kinds are a death, suicidal thoughts or an attempt, a hospital stay, an ER visit, an allergic reaction or anaphylaxis, heart rhythm, liver or kidney, blood count, mood or psychiatric, or refeeding or deficiency problems, and being made much worse: a large worsening such as a crash lasting weeks or more.
Other kinds
Unpleasant effects people tied to it, the most serious first.
Autoimmune or inflammatory flare · 1Gut side effects · 2 Show all 2Hide
Autoimmune or inflammatory flare
1 person“Until last week when I started having a MAJOR flare.”
— Pond 20039 Gut side effects
2 people“I felt too nauseous in the first few days to continue.”
— Ridge 77548 “The doc first prescribed Arava, but that also caused gut problems.”
— el_squared
All posts · not split by condition
How often it comes up
Posts that mention Leflunomide (Arava), per 1,000 posts each month. Hover or tap a point for the count.
| Month | Posts mentioning it | All posts | Per 1,000 |
|---|---|---|---|
| Oct 2009 | 0 | 105 | 0 |
| Jan 2010 | 0 | 141 | 0 |
| Feb 2010 | 0 | 113 | 0 |
| Jun 2011 | 0 | 109 | 0 |
| Nov 2011 | 0 | 124 | 0 |
| Dec 2011 | 0 | 199 | 0 |
| Jan 2012 | 0 | 232 | 0 |
| Feb 2012 | 0 | 103 | 0 |
| Mar 2012 | 0 | 190 | 0 |
| Apr 2012 | 0 | 162 | 0 |
| May 2012 | 0 | 375 | 0 |
| Jun 2012 | 0 | 238 | 0 |
| Jul 2012 | 0 | 240 | 0 |
| Aug 2012 | 0 | 485 | 0 |
| Sep 2012 | 0 | 561 | 0 |
| Oct 2012 | 0 | 526 | 0 |
| Nov 2012 | 0 | 514 | 0 |
| Dec 2012 | 0 | 699 | 0 |
| Jan 2013 | 0 | 533 | 0 |
| Feb 2013 | 0 | 447 | 0 |
| Mar 2013 | 0 | 429 | 0 |
| Apr 2013 | 0 | 499 | 0 |
| May 2013 | 0 | 606 | 0 |
| Jun 2013 | 0 | 609 | 0 |
| Jul 2013 | 0 | 616 | 0 |
| Aug 2013 | 0 | 577 | 0 |
| Sep 2013 | 0 | 364 | 0 |
| Oct 2013 | 0 | 536 | 0 |
| Nov 2013 | 0 | 385 | 0 |
| Dec 2013 | 0 | 519 | 0 |
| Jan 2014 | 0 | 944 | 0 |
| Feb 2014 | 0 | 821 | 0 |
| Mar 2014 | 0 | 425 | 0 |
| Apr 2014 | 0 | 361 | 0 |
| May 2014 | 0 | 617 | 0 |
| Jun 2014 | 0 | 489 | 0 |
| Jul 2014 | 0 | 444 | 0 |
| Aug 2014 | 0 | 622 | 0 |
| Sep 2014 | 0 | 507 | 0 |
| Oct 2014 | 0 | 678 | 0 |
| Nov 2014 | 0 | 567 | 0 |
| Dec 2014 | 0 | 629 | 0 |
| Jan 2015 | 0 | 760 | 0 |
| Feb 2015 | 0 | 873 | 0 |
| Mar 2015 | 0 | 1,276 | 0 |
| Apr 2015 | 0 | 984 | 0 |
| May 2015 | 0 | 1,496 | 0 |
| Jun 2015 | 0 | 1,046 | 0 |
| Jul 2015 | 0 | 1,211 | 0 |
| Aug 2015 | 0 | 998 | 0 |
| Sep 2015 | 0 | 1,060 | 0 |
| Oct 2015 | 0 | 1,255 | 0 |
| Nov 2015 | 0 | 1,246 | 0 |
| Dec 2015 | 0 | 924 | 0 |
| Jan 2016 | 0 | 1,282 | 0 |
| Feb 2016 | 0 | 1,051 | 0 |
| Mar 2016 | 0 | 1,002 | 0 |
| Apr 2016 | 0 | 998 | 0 |
| May 2016 | 0 | 1,045 | 0 |
| Jun 2016 | 0 | 1,230 | 0 |
| Jul 2016 | 0 | 1,619 | 0 |
| Aug 2016 | 0 | 1,729 | 0 |
| Sep 2016 | 0 | 1,785 | 0 |
| Oct 2016 | 0 | 1,220 | 0 |
| Nov 2016 | 0 | 1,092 | 0 |
| Dec 2016 | 0 | 1,211 | 0 |
| Jan 2017 | 0 | 1,660 | 0 |
| Feb 2017 | 0 | 1,988 | 0 |
| Mar 2017 | 0 | 2,078 | 0 |
| Apr 2017 | 0 | 2,133 | 0 |
| May 2017 | 0 | 2,370 | 0 |
| Jun 2017 | 0 | 2,194 | 0 |
| Jul 2017 | 0 | 2,183 | 0 |
| Aug 2017 | 0 | 2,466 | 0 |
| Sep 2017 | 0 | 2,189 | 0 |
| Oct 2017 | 0 | 3,042 | 0 |
| Nov 2017 | 0 | 1,976 | 0 |
| Dec 2017 | 0 | 2,112 | 0 |
| Jan 2018 | 0 | 2,620 | 0 |
| Feb 2018 | 0 | 2,155 | 0 |
| Mar 2018 | 5 | 2,613 | 1.9 |
| Apr 2018 | 0 | 2,251 | 0 |
| May 2018 | 1 | 2,828 | 0.35 |
| Jun 2018 | 0 | 3,871 | 0 |
| Jul 2018 | 0 | 3,067 | 0 |
| Aug 2018 | 1 | 3,757 | 0.27 |
| Sep 2018 | 0 | 3,512 | 0 |
| Oct 2018 | 0 | 3,261 | 0 |
| Nov 2018 | 0 | 2,861 | 0 |
| Dec 2018 | 0 | 2,754 | 0 |
| Jan 2019 | 0 | 3,672 | 0 |
| Feb 2019 | 0 | 2,715 | 0 |
| Mar 2019 | 0 | 3,317 | 0 |
| Apr 2019 | 0 | 3,141 | 0 |
| May 2019 | 0 | 3,855 | 0 |
| Jun 2019 | 0 | 3,392 | 0 |
| Jul 2019 | 0 | 3,312 | 0 |
| Aug 2019 | 0 | 3,943 | 0 |
| Sep 2019 | 0 | 4,035 | 0 |
| Oct 2019 | 0 | 3,922 | 0 |
| Nov 2019 | 3 | 3,508 | 0.86 |
| Dec 2019 | 0 | 3,659 | 0 |
| Jan 2020 | 0 | 4,650 | 0 |
| Feb 2020 | 0 | 4,374 | 0 |
| Mar 2020 | 0 | 4,475 | 0 |
| Apr 2020 | 0 | 3,690 | 0 |
| May 2020 | 0 | 4,543 | 0 |
| Jun 2020 | 1 | 5,701 | 0.18 |
| Jul 2020 | 0 | 6,104 | 0 |
| Aug 2020 | 0 | 10,333 | 0 |
| Sep 2020 | 0 | 11,958 | 0 |
| Oct 2020 | 0 | 14,568 | 0 |
| Nov 2020 | 0 | 16,546 | 0 |
| Dec 2020 | 0 | 20,764 | 0 |
| Jan 2021 | 0 | 24,562 | 0 |
| Feb 2021 | 0 | 24,672 | 0 |
| Mar 2021 | 0 | 29,476 | 0 |
| Apr 2021 | 0 | 28,509 | 0 |
| May 2021 | 0 | 25,791 | 0 |
| Jun 2021 | 0 | 27,871 | 0 |
| Jul 2021 | 0 | 27,220 | 0 |
| Aug 2021 | 0 | 30,808 | 0 |
| Sep 2021 | 0 | 30,074 | 0 |
| Oct 2021 | 0 | 22,132 | 0 |
| Nov 2021 | 0 | 27,722 | 0 |
| Dec 2021 | 1 | 31,872 | 0.03 |
| Jan 2022 | 0 | 42,317 | 0 |
| Feb 2022 | 0 | 38,697 | 0 |
| Mar 2022 | 0 | 44,305 | 0 |
| Apr 2022 | 0 | 44,333 | 0 |
| May 2022 | 0 | 50,594 | 0 |
| Jun 2022 | 0 | 49,058 | 0 |
| Jul 2022 | 0 | 53,485 | 0 |
| Aug 2022 | 0 | 54,455 | 0 |
| Sep 2022 | 1 | 56,936 | 0.02 |
| Oct 2022 | 0 | 58,511 | 0 |
| Nov 2022 | 0 | 59,198 | 0 |
| Dec 2022 | 0 | 61,576 | 0 |
| Jan 2023 | 2 | 61,004 | 0.03 |
| Feb 2023 | 0 | 50,133 | 0 |
| Mar 2023 | 0 | 59,925 | 0 |
| Apr 2023 | 0 | 54,251 | 0 |
| May 2023 | 0 | 57,768 | 0 |
| Jun 2023 | 2 | 52,679 | 0.04 |
| Jul 2023 | 0 | 56,401 | 0 |
| Aug 2023 | 0 | 65,435 | 0 |
| Sep 2023 | 0 | 61,835 | 0 |
| Oct 2023 | 0 | 58,419 | 0 |
| Nov 2023 | 0 | 53,662 | 0 |
| Dec 2023 | 0 | 60,643 | 0 |
| Jan 2024 | 0 | 71,818 | 0 |
| Feb 2024 | 0 | 70,045 | 0 |
| Mar 2024 | 4 | 68,261 | 0.06 |
| Apr 2024 | 0 | 64,374 | 0 |
| May 2024 | 0 | 67,698 | 0 |
| Jun 2024 | 0 | 64,720 | 0 |
| Jul 2024 | 0 | 65,335 | 0 |
| Aug 2024 | 0 | 68,517 | 0 |
| Sep 2024 | 0 | 70,168 | 0 |
| Oct 2024 | 1 | 72,607 | 0.01 |
| Nov 2024 | 1 | 71,802 | 0.01 |
| Dec 2024 | 1 | 74,401 | 0.01 |
| Jan 2025 | 0 | 77,909 | 0 |
| Feb 2025 | 0 | 65,110 | 0 |
| Mar 2025 | 1 | 69,905 | 0.01 |
| Apr 2025 | 0 | 61,606 | 0 |
| May 2025 | 0 | 65,733 | 0 |
| Jun 2025 | 1 | 60,540 | 0.02 |
| Jul 2025 | 2 | 62,105 | 0.03 |
| Aug 2025 | 0 | 64,578 | 0 |
| Sep 2025 | 1 | 61,704 | 0.02 |
| Oct 2025 | 3 | 59,204 | 0.05 |
| Nov 2025 | 0 | 58,944 | 0 |
| Dec 2025 | 0 | 62,830 | 0 |
| Jan 2026 | 0 | 63,321 | 0 |
| Feb 2026 | 0 | 53,085 | 0 |
| Mar 2026 | 0 | 59,208 | 0 |
| Apr 2026 | 0 | 53,989 | 0 |
| May 2026 | 0 | 57,541 | 0 |
| Jun 2026 | 1 | 55,301 | 0.02 |
| Jul 2026 | 2 | 56,391 | 0.04 |
| Aug 2026 | 0 | 56,825 | 0 |
| Sep 2026 | 0 | 57,143 | 0 |
Forum and Reddit posts, 4,007,898 in all, counted per month. A mention means the post names the treatment, not that the writer took it. All trends
All 9 people who tried it
-
ME/CFS improved on leflunomide, then relapsed with a major flare
Pond 20039 took leflunomide (Arava) for about 2.5 months. They felt great on 10 mg in the first month and even better on 20 mg in the second, but then began a major flare. Blood tests showed the liver was not tolerating the drug, so it was stopped. They were…
-
Housebound with long COVID and brain fog, some activities back on low-dose naltrexone
Housebound with long COVID plus MCTD, fibromyalgia and other autoimmune issues, this person had never-ending pain, swelling, odd sensations, brain fog and PEM. Immunosuppressants and steroids did nothing. In mid-2026 low-dose naltrexone (3 mg, titrating to…
-
Bedbound with ME/CFS, still bedbound 90% of the time and not recovering
Plover 62450 traced her ME/CFS to glandular fever (mono) at 19; symptoms crept up slowly and she became bedbound in 2016/2017, losing more function after the pandemic began. She took immunosuppressants for Sjögren's and fludrocortisone for POTS; aquatic…
-
Severe ME/CFS worsened over more than a decade, still severe
Ridge 77548 described their ME/CFS as severe and said it had deteriorated over more than a decade. Valcyte, gabapentin, Ativan, Botox with Ajovy for migraines and pravastatin each helped them to some degree, while Arava, low-dose naltrexone, Lyrica and…
-
Long COVID with fatigue, brain fog, pain and POTS, somewhat better with Ozempic
Long COVID since May 2022 left them with fatigue, brain fog, pain, IBS, anxiety and POTS. Ozempic, begun in September 2022 for PCOS, slowly improved their energy, joint pain, IBS and brain fog. Stopping it for surgery in summer 2024 brought symptoms back;…
-
el_squared on Phoenix Rising
el_squared was functionally ill for about 20 years with celiac disease, fibromyalgia and IBS before CFS was diagnosed at a Stanford clinic in 2015, when she was on disability, very weak and often in bed. A two-week course of Xifaxan made her much more…
-
merylg on Phoenix Rising
merylg was bed-bound after a major CFS/ME/FM/MCS crash in 2011 and improved to mostly housebound on methylation protocols, later crediting B2 (riboflavin) with better sleep, less muscle and tendon pain and healing hand eczema. She could not tolerate methyl…
-
Newly ill with ME/CFS, tried something but too early to tell any difference
A person started something in March 2018 and, a few days in, could not tell any major difference. They said it was hard to judge because they had also become ill around the same time, and that they might be able to tell a few weeks down the line. No later…
-
Evangeline on Phoenix Rising
Evangeline had CFS long before her autoimmune disease and was couch-bound by exhaustion and joint pain that stopped her driving, shopping or lifting a cup. From December 2014 she took Rituximab infusions, which gave a small benefit at about eight weeks, wore…
The first one credits Leflunomide (Arava) for their improvement; the other 8 tried it without crediting it.
All 2 people who tried it
-
Housebound with long COVID and brain fog, some activities back on low-dose naltrexone
Housebound with long COVID plus MCTD, fibromyalgia and other autoimmune issues, this person had never-ending pain, swelling, odd sensations, brain fog and PEM. Immunosuppressants and steroids did nothing. In mid-2026 low-dose naltrexone (3 mg, titrating to…
-
Long COVID with fatigue, brain fog, pain and POTS, somewhat better with Ozempic
Long COVID since May 2022 left them with fatigue, brain fog, pain, IBS, anxiety and POTS. Ozempic, begun in September 2022 for PCOS, slowly improved their energy, joint pain, IBS and brain fog. Stopping it for surgery in summer 2024 brought symptoms back;…
None of them credit Leflunomide (Arava) for their improvement.
All 7 people who tried it
-
ME/CFS improved on leflunomide, then relapsed with a major flare
Pond 20039 took leflunomide (Arava) for about 2.5 months. They felt great on 10 mg in the first month and even better on 20 mg in the second, but then began a major flare. Blood tests showed the liver was not tolerating the drug, so it was stopped. They were…
-
Bedbound with ME/CFS, still bedbound 90% of the time and not recovering
Plover 62450 traced her ME/CFS to glandular fever (mono) at 19; symptoms crept up slowly and she became bedbound in 2016/2017, losing more function after the pandemic began. She took immunosuppressants for Sjögren's and fludrocortisone for POTS; aquatic…
-
Severe ME/CFS worsened over more than a decade, still severe
Ridge 77548 described their ME/CFS as severe and said it had deteriorated over more than a decade. Valcyte, gabapentin, Ativan, Botox with Ajovy for migraines and pravastatin each helped them to some degree, while Arava, low-dose naltrexone, Lyrica and…
-
el_squared on Phoenix Rising
el_squared was functionally ill for about 20 years with celiac disease, fibromyalgia and IBS before CFS was diagnosed at a Stanford clinic in 2015, when she was on disability, very weak and often in bed. A two-week course of Xifaxan made her much more…
-
merylg on Phoenix Rising
merylg was bed-bound after a major CFS/ME/FM/MCS crash in 2011 and improved to mostly housebound on methylation protocols, later crediting B2 (riboflavin) with better sleep, less muscle and tendon pain and healing hand eczema. She could not tolerate methyl…
-
Newly ill with ME/CFS, tried something but too early to tell any difference
A person started something in March 2018 and, a few days in, could not tell any major difference. They said it was hard to judge because they had also become ill around the same time, and that they might be able to tell a few weeks down the line. No later…
-
Evangeline on Phoenix Rising
Evangeline had CFS long before her autoimmune disease and was couch-bound by exhaustion and joint pain that stopped her driving, shopping or lifting a cup. From December 2014 she took Rituximab infusions, which gave a small benefit at about eight weeks, wore…
The first one credits Leflunomide (Arava) for their improvement; the other 6 tried it without crediting it.